Monoclonal Gammopathy of Undetermined Significance - 18 Studies Found

Suspended : Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance
:
  • Neuropathy
  • Nonmalignant Monoclonal Gammopathy of Undetermined Signific
    : 2008-04-22
    : Drug: Lenalidomide Subjects will receive lenalidomide 25 mg per day for days 1-21 followed by 7 days res
Completed : Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)
:
  • Smoldering Myeloma
  • Monoclonal Gammopathy of Undetermined Significance<
    : 2010-04-22
Completed : Unravel MGUS (Monoclonal Gammopathy of Unknown Significance)
: Monoclonal Gammopathy of Unknown Significance
: 2016-09-15
:
  • Other: Blood sample taken
  • Other: Answering
Completed : A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma
:
  • Monoclonal Gammopathy of Undetermined Significance
  • Multiple Mye
    : 2010-09-23
    : Biological: Siltuximab 15mg/kg IV infusion every 3 weeks for 4 cycles. If applicable extended dosing of
Completed : Prognostic Study of Markers of Angiogenesis and Coagulability in Patients With Monoclonal Gammopathy
:
  • Monoclonal Gammopathy
  • Monoclonal Gammopat
    : 2011-08-23
    : Other: blood and bone marrow samples Specific tests of the
Active, not recruiting : Study of DNA Copy Numbers Variations and Gene Expression Profile of Bone Marrow Plasma Cells From MGUS and SMM.
:
  • Monoclonal Gammopathy of Undetermined Significance
  • Smoldering M
    : 2010-03-01
    : Genetic: Genetic study of DNA copies Gene expression profiling, DNA copy number variation
Recruiting : Prospective Observational Study of Clinical and Genomic Predictors of Progression to Myeloma in Asymptomatic Monoclonal Gammopathies
:
  • Monoclonal Gammopathy of Unknown Significance
  • Smoldering Multip
    : 2016-03-30
    : Procedure: Blood Collection Blood (about 1-2 tablespoons) collected for biomarker and routine tests and
Terminated : Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance
: Precancerous Condition
: 2007-12-20
: Biological: Rituximab Rituximab will be given as a 375 mg/m^2 intravenous infusion once weekly for four
Not yet recruiting : Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat
:
  • Monoclonal Gammopathies
  • Overweight
  • Multiple Myeloma
  • Smoldering Multiple Myeloma
  • Drug: 18-NaF PET The patient w
Next >>>